Skip to main content
SpringerLink
Log in

Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, controlled study Reply to letter to the editor

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Ferlazzo E, Giussani G, Gasparini S et al (2022) Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study. Neurol Sci 43(8):5133–5141. https://doi.org/10.1007/s10072-022-06121-9

  2. Panigrahi B, Tripathi M (2022) Rapid versus slow withdrawal of antiepileptic monotherapy in 2‑year seizure‑free adult patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, and controlled study-letter to the editor. Neurol Sci. https://doi.org/10.1007/s10072-022-06368-2

  3. Gasparini S, Ferlazzo E, Giussani G, Italiano D, Cianci V, Sueri C, Spina E, Beghi E, Aguglia U (2016) Rapid versus slow withdrawal of antiepileptic monotherapy in 2-year seizure-free adult patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study. Neurol Sci 37(4):579–583. https://doi.org/10.1007/s10072-016-2483-3

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Surgical Sciences, “Magna Græcia” University of Catanzaro, Catanzaro, Italy

    Edoardo Ferlazzo, Sara Gasparini & Umberto Aguglia

  2. Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, 89100, Reggio Calabria, Italy

    Edoardo Ferlazzo, Sara Gasparini & Umberto Aguglia

  3. Laboratory of Neurological Disorders, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy

    Giorgia Giussani & Elisa Bianchi

Authors
  1. Edoardo Ferlazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giorgia Giussani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisa Bianchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Umberto Aguglia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Umberto Aguglia.

Ethics declarations

Ethical approval

Research involving human participants and/or animals: not applicable (response to a Letter to the Editor).

Conflict of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferlazzo, E., Gasparini, S., Giussani, G. et al. Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, controlled study Reply to letter to the editor. Neurol Sci 44, 385–387 (2023). https://doi.org/10.1007/s10072-022-06405-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-022-06405-0

Search

Navigation